{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-138870","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:31.880351+00:00","generated_at":"2026-05-15T07:46:44.564508+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Inovio suspends ATM prospectus; raised $3.2M from 1.3M shares under program","bullets":["On April 1, 2026, Inovio notified Oppenheimer of suspension and termination of the ATM prospectus from August 13, 2024.","No further sales under the ATM program until a new prospectus is filed; the Sales Agreement remains in effect.","As of April 1, 2026, Inovio had sold 1,319,644 shares for gross proceeds of $3.2 million under the ATM program."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-138870","json":"https://secwatch.observer/filing/0001193125-26-138870.json","markdown":"https://secwatch.observer/filing/0001193125-26-138870.md","text":"https://secwatch.observer/filing/0001193125-26-138870.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312526138870/0001193125-26-138870-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312526138870/d107839d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:46:44.564508+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}